Zurcher Kantonalbank Zurich Cantonalbank Has $1.68 Million Stock Position in Cytokinetics, Incorporated (NASDAQ:CYTK)

Zurcher Kantonalbank Zurich Cantonalbank boosted its stake in Cytokinetics, Incorporated (NASDAQ:CYTK – Free Report) by 14.5% in the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 20,137 shares of the biopharmaceutical company’s stock after purchasing an additional 2,557 shares during the quarter. […]

Leave a Reply

Your email address will not be published.

Previous post Prologis (NYSE:PLD) Downgraded by StockNews.com to “Sell”
Next post Masonite International (NYSE:DOOR) Receives New Coverage from Analysts at StockNews.com